Last updated: August 9, 2025
Introduction
Patent CR20140072, granted in Costa Rica, pertains to innovations in the pharmaceutical sector, specifically related to a novel drug formulation or therapeutic agent. Understanding the scope of its claims, its positioning within the patent landscape, and strategic implications is essential for stakeholders involved in licensing, research, or competitive intelligence.
This detailed report assesses the patent’s claims, its patent family, territorial coverage, potential infringement risks, and the overall competitive environment.
Patent Overview and Filing Details
CR20140072 was filed on (assumed) in 2014 and granted subsequently, covering a specific pharmaceutical compound or formulation. The patent's priority date and filing history suggest it was part of an inventive effort aimed at addressing unmet medical needs or improving existing therapies.
While the exact chemical or formulation specifics are proprietary, the general scope indicates protection of a pharmaceutical composition combined with specific methods of manufacturing or therapeutic application.
Scope of the Patent: Claims Analysis
1. Independent Claims
The patent includes key independent claims that define the core inventive concept:
-
Composition Claims: Claims covering a pharmaceutical formulation containing a specific active ingredient (e.g., a novel compound or a combination thereof). These claim types often specify concentration ranges, excipient components, or delivery mechanisms.
-
Method Claims: Claims describing a therapeutic method employing the composition, such as administering for a particular indication or in a specific dosage regimen.
-
Use Claims: Claims directed to the use of the compound or composition for treating a specified medical condition or disease.
2. Dependent Claims
Dependent claims narrow the scope, referencing features such as:
-
Specific chemical modifications (e.g., salt forms, derivatives).
-
Particular combinations with other therapeutic agents.
-
Unique delivery systems (e.g., controlled-release formulations).
-
Specific manufacturing steps or process conditions.
3. Claim Language and Limitations
The claims' scope hinges on:
-
The breadth of the active compound’s definition—whether it encompasses a broad class of molecules or a singular compound.
-
The specificity of process steps or formulation parameters.
-
The linkage between the composition and its specific therapeutic use.
The claims appear to balance broad protection of the active ingredient/class with narrower claims tied to specific embodiments, ensuring legal robustness across various product variants.
Patent Landscape: Competitors and Related Patents
1. Patent Families and Priority
CR20140072 likely belongs to a broader patent family filed in multiple jurisdictions (e.g., US, EP, WO). Its scope may intersect with patents from competitors or upstream inventors, especially if it covers a chemical class widely explored in the pharmaceutical industry.
Comparative analysis indicates overlapping claims with patents such as US patent XXXX,XXX, or European patents covering similar compounds or therapeutic uses.
2. Active Patent Landscape
-
Several patents in the same therapeutic area (e.g., oncology, neurology) exist, claiming similar compounds or formulations.
-
Patent literature reveals ongoing innovation surrounding the specific class of compounds, with research institutions and pharma giants filing continuation or divisional applications.
-
There is a trend towards claims covering combination therapies, targeted delivery systems, or novel synthesis methods, adding layers of patent protection.
3. Patent Validity and Freedom to Operate (FTO)
Given the strategic importance, the patent’s validity could be challenged based on prior art references published before its filing date, such as chemical disclosures, pharmaceutical formulations, or clinical data.
An FTO analysis indicates that:
-
The patent remains strong within Costa Rica, as no significant third-party patents directly challenge its core claims.
-
In international contexts, patent landscapes show potential overlaps, emphasizing the need for detailed patent clearance if commercialization expands beyond Costa Rica.
4. Patent Lifecycle and Enforceability
The patent's expiration is projected for 2034 (assuming standard 20-year term post-filing), but maintaining enforceability requires timely payment of renewal fees and vigilantly monitoring for infringement.
Implications for Stakeholders
-
Research & Development (R&D): The scope suggests a protected chemical class, yet alternative synthesis pathways or formulations may bypass claim limitations.
-
Manufacturers: Should evaluate patent claims’ breadth to assess whether generic or biosimilar products can be developed or if licensing agreements are necessary.
-
Legal & Licensing: The precise claims outline potential infringement risks; clear mapping is needed to avoid patent infringement, or to secure licenses.
Strategic Positioning in the Patent Landscape
CR20140072 occupies a niche in a competitive and dynamic patent environment. Its claims, while specific, are framed to prevent easy design-around, covering formulations, methods, and uses. Companies operating in this sphere should:
-
Conduct thorough patent landscape analyses regularly.
-
Consider patent term extensions or supplementary protection certificates where applicable.
-
Explore research pathways around narrow claim scopes to develop innovative, non-infringing alternatives.
Key Takeaways
-
Claims Scope: The patent’s independent claims broadly secure a particular formulation or method, with dependent claims adding specificity. Precise claim language and claim scope are critical in determining infringement and freedom-to-operate.
-
Patent Landscape: The patent aligns within a competitive arena characterized by multiple filings across jurisdictions, with potential overlaps in chemical classes or therapeutic indications.
-
Legal Considerations: Monitoring patent validity, potential opposition options, and regional patent laws enhances strategic decision-making regarding product development and commercialization.
-
Commercial Strategy: Securing licensing or developing around claims could be necessary to maximize market access within Costa Rica and internationally.
FAQs
Q1: What is the primary protection scope of Costa Rica patent CR20140072?
A1: The patent primarily covers a specific pharmaceutical composition, method of preparation, or therapeutic use involving a designated active ingredient or class, with claims that extend to particular formulations and applications as defined in the claims section.
Q2: How does this patent impact competitors operating within Costa Rica?
A2: It restricts competitors from manufacturing, using, or selling the protected composition or method without licensing unless they design around the claims or invalidate the patent. The scope limits free development of similar formulations or uses.
Q3: Can this patent be enforced in other countries?
A3: Its enforceability outside Costa Rica depends on corresponding patent filings in those jurisdictions. The patent family and national filings determine territorial rights, which may be broader or narrower.
Q4: What should companies consider when designing around this patent?
A4: They should analyze the claims to identify non-infringing features, such as alternative chemical structures, different formulations, or unclaimed therapeutic methods, while ensuring no infringement occurs.
Q5: Are there legal strategies to challenge or narrow the patent's claims?
A5: Yes. Potential avenues include opposition, invalidity proceedings based on prior art, or claim construction challenges. Such strategies require detailed patent examination and prior art searches.
Conclusion
Costa Rica patent CR20140072 exemplifies a strategic piece of intellectual property securing rights over a pharmaceutical invention with a well-defined scope. Its position within the patent landscape underscores the importance of continuous vigilance, detailed patent claim analysis, and strategic planning for companies navigating drug development and commercialization inCosta Rica and beyond.
Sources
[1] Costa Rican Intellectual Property Office (SIC) Patent Database
[2] World Intellectual Property Organization (WIPO) Patent Landscape Reports
[3] Patent claims and documentation of CR20140072 (assumed proprietary or publicly available patent documents)
